\-\ Texto\\:\\ \ \(0\)\
\-\ blood\\ pressure\\ measured\\ 162\\/96\\.\\ \\ remaining\\ vital\\ signs\\ were\\ normal\\.\\ \\ labs\\ to\\ include\\ cbc\\,\\ comprehensive\\ metabolic\\ panel\\,\\ tsh\\,\\ aldosterone\\,\\ vma\\ and\\ metanephrines\\ were\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ percutaneous\\ transluminal\\ angioplasty\\.\\ \\ in\\ patient\\'s\\ who\\ undergo\\ pta\\,\\ periodic\\ blood\\ pressure\\ measurements\\ should\\ be\\ followed\\.\ \(0\)\
\-\ string\\ of\\ beads\\ appearance\\ with\\ alternating\\ segments\\ of\\ stricture\\ and\\ dilation\\ of\\ the\\ mid\\ to\\ distal\\ right\\ renal\\ artery\\.\\ \\ the\\ patient\\ was\\ found\\ to\\ have\\ two\\ left\\ renal\\ arteries\\,\\ with\\ the\\ more\\ inferior\\ artery\\ demonstrating\\ the\\ string\\ of\\ beads\\ appearance\\.\ \(0\)\
\-\ fibromuscular\\ dysplasia\ \(11\)\
\-\ 1\\.\\ \\ fibromuscular\\ dysplasia\\.\ \(0\)\
\-\ 2\\.\\ \\ atherosclerotic\\ renal\\ artery\\ disease\\,\\ however\\ this\\ is\\ most\\ likely\\ to\\ be\\ seen\\ at\\ the\\ origin\\ of\\ the\\ renal\\ artery\\ in\\ an\\ older\\ patient\\ with\\ cardiovascular\\ risk\\ factors\\.\ \(0\)\
\-\ 3\\.\\ \\ polyarteritis\\ nodosa\\,\\ however\\ the\\ aneurysms\\ tend\\ to\\ be\\ smaller\\ and\\ more\\ peripheral\\.\ \(0\)\
\-\ 4\\.\\ \\ other\\ vasculitides\\.\ \(0\)\
\-\ 47\\ year\\ old\\ female\\ with\\ hypertension\\,\\ uncontrolled\\ with\\ multiple\\ antihypertensive\\ medications\\.\\ \\ patient\\ is\\ a\\ nonsmoker\\ and\\ generally\\ feels\\ well\\.\ \(0\)\
\-\ this\\ patient\\ underwent\\ pta\\ and\\ had\\ a\\ significant\\ decrease\\ in\\ blood\\ pressure\\,\\ allowing\\ good\\ control\\ with\\ a\\ single\\ antihypertensive\\ medication\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ antihypertensive\\:\\ 0\\.07467440944593158\ \(0\)\
\-\ beads\\:\\ 0\\.06980390551592396\ \(0\)\
\-\ pta\\:\\ 0\\.06650386685148318\ \(0\)\
\-\ string\\:\\ 0\\.059803067214954146\ \(0\)\
\-\ fibromuscular\\:\\ 0\\.05758986410305716\ \(0\)\
\-\ renal\\:\\ 0\\.053211928486177604\ \(0\)\
\-\ artery\\:\\ 0\\.05273637289343418\ \(0\)\
\-\ pressure\\:\\ 0\\.052164760256305794\ \(0\)\
\-\ 162\\/96\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ aldosterone\\:\\ 0\\.039983969612945015\ \(0\)\
\-\ transluminal\\:\\ 0\\.039983969612945015\ \(0\)\
\-\ metanephrines\\:\\ 0\\.038493388926666365\ \(0\)\
\-\ nonsmoker\\:\\ 0\\.03733720472296579\ \(0\)\
\-\ vma\\:\\ 0\\.036392533444240635\ \(0\)\
\-\ vasculitides\\:\\ 0\\.036392533444240635\ \(0\)\
\-\ blood\\:\\ 0\\.036255094391336264\ \(0\)\
\-\ dysplasia\\:\\ 0\\.03495441153828709\ \(0\)\
\-\ polyarteritis\\:\\ 0\\.03490195275796198\ \(0\)\
\-\ nodosa\\:\\ 0\\.03325193342574159\ \(0\)\
\-\ uncontrolled\\:\\ 0\\.0320023890899028\ \(0\)\
\-\ comprehensive\\:\\ 0\\.030996399377773484\ \(0\)\
\-\ alternating\\:\\ 0\\.030996399377773484\ \(0\)\
\-\ feels\\:\\ 0\\.030154332385557033\ \(0\)\
\-\ measurements\\:\\ 0\\.029430177243716833\ \(0\)\
\-\ allowing\\:\\ 0\\.028599386310684816\ \(0\)\
\-\ angioplasty\\:\\ 0\\.028410952921198416\ \(0\)\
\-\ periodic\\:\\ 0\\.02822913261129546\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.026562896216852653\ \(0\)\
\-\ aneurysms\\:\\ 0\\.026562896216852653\ \(0\)\
\-\ panel\\:\\ 0\\.026069061088332835\ \(0\)\
\-\ appearance\\:\\ 0\\.025325456753726855\ \(0\)\
\-\ tend\\:\\ 0\\.02510480057209522\ \(0\)\
\-\ segments\\:\\ 0\\.024912876884632267\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.024819516752494036\ \(0\)\
\-\ however\\:\\ 0\\.02465666378857068\ \(0\)\
\-\ measured\\:\\ 0\\.02404731167912363\ \(0\)\
\-\ tsh\\:\\ 0\\.02404731167912363\ \(0\)\
\-\ stricture\\:\\ 0\\.02373788559258673\ \(0\)\
\-\ percutaneous\\:\\ 0\\.023445901465378796\ \(0\)\
\-\ 47\\:\\ 0\\.02323722841285061\ \(0\)\
\-\ remaining\\:\\ 0\\.023036635085489518\ \(0\)\
\-\ undergo\\:\\ 0\\.022477624919628455\ \(0\)\
\-\ older\\:\\ 0\\.02230393221476502\ \(0\)\
\-\ medication\\:\\ 0\\.02230393221476502\ \(0\)\
\-\ patient\\:\\ 0\\.022191500800942694\ \(0\)\
\-\ more\\:\\ 0\\.02214690475971157\ \(0\)\
\-\ metabolic\\:\\ 0\\.021867350123481392\ \(0\)\
\-\ smaller\\:\\ 0\\.021464712898987524\ \(0\)\
\-\ vital\\:\\ 0\\.021182023861420506\ \(0\)\
\-\ dilation\\:\\ 0\\.020870604565722553\ \(0\)\
\-\ be\\:\\ 0\\.02048326512969838\ \(0\)\
\-\ origin\\:\\ 0\\.020298852974174025\ \(0\)\
\-\ decrease\\:\\ 0\\.020260329769575487\ \(0\)\
\-\ control\\:\\ 0\\.0201841321147066\ \(0\)\
\-\ were\\:\\ 0\\.020106594162589857\ \(0\)\
\-\ generally\\:\\ 0\\.019925933286997398\ \(0\)\
\-\ factors\\:\\ 0\\.019890076070186134\ \(0\)\
\-\ cbc\\:\\ 0\\.01978396969016779\ \(0\)\
\-\ medications\\:\\ 0\\.019749078331715228\ \(0\)\
\-\ demonstrating\\:\\ 0\\.019220585233502164\ \(0\)\
\-\ good\\:\\ 0\\.018945404791460983\ \(0\)\
\-\ mid\\:\\ 0\\.01851695030521687\ \(0\)\
\-\ arteries\\:\\ 0\\.018328516915730474\ \(0\)\
\-\ limits\\:\\ 0\\.0182498113950363\ \(0\)\
\-\ single\\:\\ 0\\.017946426375598092\ \(0\)\
\-\ hypertension\\:\\ 0\\.017454824105182322\ \(0\)\
\-\ 4\\.\\:\\ 0\\.017432538706739886\ \(0\)\
\-\ risk\\:\\ 0\\.016037340141756926\ \(0\)\
\-\ peripheral\\:\\ 0\\.016020379906808897\ \(0\)\
\-\ signs\\:\\ 0\\.015582258725316345\ \(0\)\
\-\ labs\\:\\ 0\\.0153988290514774\ \(0\)\
\-\ underwent\\:\\ 0\\.015192725572426007\ \(0\)\
\-\ 3\\.\\:\\ 0\\.015149607316791333\ \(0\)\
\-\ inferior\\:\\ 0\\.01502236456662727\ \(0\)\
\-\ followed\\:\\ 0\\.01484391643201436\ \(0\)\
\-\ should\\:\\ 0\\.014115070165226944\ \(0\)\
\-\ 2\\.\\:\\ 0\\.014080021460104964\ \(0\)\
\-\ \\,\\:\\ 0\\.014026428265144423\ \(0\)\
\-\ found\\:\\ 0\\.013953500593016126\ \(0\)\
\-\ normal\\:\\ 0\\.013881994348177213\ \(0\)\
\-\ 1\\.\\:\\ 0\\.01382999568029845\ \(0\)\
\-\ two\\:\\ 0\\.012680472733761688\ \(0\)\
\-\ likely\\:\\ 0\\.012488549046298739\ \(0\)\
\-\ include\\:\\ 0\\.01242048439393931\ \(0\)\
\-\ distal\\:\\ 0\\.012037712896093403\ \(0\)\
\-\ significant\\:\\ 0\\.011905943787845718\ \(0\)\
\-\ who\\:\\ 0\\.011543877767573586\ \(0\)\
\-\ to\\:\\ 0\\.011063940633237986\ \(0\)\
\-\ most\\:\\ 0\\.01022194373952371\ \(0\)\
\-\ other\\:\\ 0\\.010205381081359838\ \(0\)\
\-\ well\\:\\ 0\\.010015963486884202\ \(0\)\
\-\ this\\:\\ 0\\.00995997112242625\ \(0\)\
\-\ \\'s\\:\\ 0\\.009761899577031321\ \(0\)\
\-\ have\\:\\ 0\\.009587762064067834\ \(0\)\
\-\ had\\:\\ 0\\.00955362600642854\ \(0\)\
\-\ multiple\\:\\ 0\\.009325419707146471\ \(0\)\
\-\ female\\:\\ 0\\.009102384826154579\ \(0\)\
\-\ seen\\:\\ 0\\.008749365881179742\ \(0\)\
\-\ within\\:\\ 0\\.008446276727389025\ \(0\)\
\-\ disease\\:\\ 0\\.007236982078837845\ \(0\)\
\-\ in\\:\\ 0\\.006550216012542823\ \(0\)\
\-\ a\\:\\ 0\\.006164763758838361\ \(0\)\
\-\ an\\:\\ 0\\.006122615877122953\ \(0\)\
\-\ at\\:\\ 0\\.005998772812599135\ \(0\)\
\-\ is\\:\\ 0\\.005826847444401302\ \(0\)\
\-\ was\\:\\ 0\\.0051206089233869784\ \(0\)\
\-\ the\\:\\ 0\\.005014222761271401\ \(0\)\
\-\ left\\:\\ 0\\.0049539133122948956\ \(0\)\
\-\ year\\:\\ 0\\.0049539133122948956\ \(0\)\
\-\ right\\:\\ 0\\.00467166688658247\ \(0\)\
\-\ and\\:\\ 0\\.004663445744357991\ \(0\)\
\-\ old\\:\\ 0\\.004533339880115309\ \(0\)\
\-\ with\\:\\ 0\\.003637435526110562\ \(0\)\
\-\ of\\:\\ 0\\.0030182331812950366\ \(0\)\
\-\ \\.\\:\\ 0\\.002575095882709056\ \(0\)\
